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Abstract 
The new heteroaromatic compounds, 7,9-di(2-pyridyl)[1,2,3]triazolo[5',1':6,1]pyrido[3,2-d] 
pyrimidines 11a-c, were synthesized in two steps from readily available triazolopyridines 1a-c. 
Regioselective lithiation of 1a-c followed by treatment with 2-cyanopyridine gave a mixture of 
compounds 5a-c, and 11a-c in moderate to low yields, together with gums. Similar reactions 
with the triazolopyridine 1d gave as the only identified compound the triazolopyridine derivative 
5d. 
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Introduction 
 
The synthetic chemical mimicry of the double-helix structural motif is an interesting area of 
research with intense activity in recent years.2 Oligopyridines and related compounds are very 
useful helicating ligands.2,3 We have recently discovered a facile route to new potential helicating 
ligands 2a-d, 3a-d, 5d, and 6 from triazolopyridines 1a-d (scheme 1).4,5 Following this study we 
have designed new ligands 7-10, which can be easily accessible from compound 5d if the 
methodology summarized above is applicable (see scheme 2). The understanding that the 
availability of 5d is important to success, led us to try its synthesis in an attempt to improve the 
reported yield.5 We wish to report here our results in this project, and the discovery of a new 
heterocyclic system, [1,2,3]triazolo[5',1':6,1]pyrido[3,2-d]pyrimidine 11, when we have tested 
the generality of the studied reaction. 
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Scheme 1 
 
Results and Discussion 
 
We have reported that reaction of triazolopyridine 1d in THF solution at –40ºC with LDA gave 
the 7-lithio derivative 4d which reacted with 2-pyridine carbaldehyde to form an unstable 
diarylmethyl alkoxide intermediate, which provides rapid access to ketone 5d by spontaneous air 
oxidation in work-up, with 35% yield.5 As we have found later that lithiation reactions of 
triazolopyridines 1 give better results using toluene as solvent and n-BuLi as lithiating agent,6 we 
thought that in these conditions, and with 2-cyanopyridine as coreagent, we could improve the 
yield of 5d. However the new reaction gave, as only characterized product, the compound 5d in 
almost the same yield.  
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Scheme 2 
 
In the context of our research with triazolopyridines it was also interesting to know the scope 
of this type of reaction, and it was performed with compounds 1a-c. In the conditions above 
indicated, the 7-lithio derivatives 4a-c were formed. Subsequent reactions with 2-cyanopyridine 
gave the corresponding 7-pyridylcarbonyl derivatives 5a-c together with other compounds 
(scheme 3). In all cases a new compound was found. A careful study of their analytical and 
spectroscopic data suggests that this was a novel triazolopyridopyrimidine system 11. 
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Scheme 3 
 
We will discuss the more interesting features for compound 11b with molecular weight of 
339.1233 consistent with a molecular formula of C19H13N7. The 13C NMR spectrum showed the 
expected 19 signals. The 1H and 13C NMR spectra showed the characteristic pattern of two 
different 2-substituted pyridines. In addition, in the 1H NMR spectrum, contains an interesting 
AB pair of doublets at δ 8.65 and 7.51 with a coupling constant of 9.6 Hz, corresponding to H4 
and H5 protons in a triazolo[1,5-a]pyridine ring. 
The formation of the new triazolopyridopyrimidine system could be explained by the 
following mechanism (scheme 4). Reaction of the corresponding lithio derivative with a mole of 
2-cyanopyridine gives the intermediate 12 which reacts with a second mole of reagent forming a 
new intermediate 13 that could in turn produce 14. Here the negative charge is delocalized 
through a strongly acceptor system made of two nitrogen atoms in the pyrimidine part of the 
structure, which permits the proposed cyclization. Then compounds 11 are formed by a hydride 
elimination. Another possibility is an electrocyclic process (6π) from N-protonated 13 followed 
by oxidation.  
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Scheme 4 
 
In the reaction with triazolopyridine 1a two minor (5% and 2%) compounds were also 
formed, one identified as 15 (see scheme 3), easily formed from 5a by triazolo ring opening and 
loss of dinitrogen in acid medium.7 The other one was unexpected, and it was shown by HRMS 
to have formula C18H13N5. A study of their 1H and 13C NMR spectra shows the presence of two 
different 2-substituted pyridines. A 2,3,6-trisubstituted pyridine was also present (a pair of 
doublets at 9.25 and 7.42 ppm with a coupling constant of 8.5 Hz in the 1H NMR spectrum) and 
a methyl group. All these data lead us to propose the structure 16 for this compound. Its 
formation could be explained from the same intermediate 13 proposed to interpret the formation 
of compounds 11. This anion could undergo a ring-closure/triazole-ring opening leading to a 
diazo anion 17, a 1,5-transfer of hydrogen in this anion to form 18 that, after protonation and 
nitrogen elimination, gives 16 as is shown in scheme 5. In the reaction with triazolopyridine 1b a 
further compound was identified as 19 probably formed from 12b by hydride reduction, in this 
reaction the known compound 204 was also formed in very low yield (5%).  
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Experimental Section 
 
General Procedures. Melting points were determined on a Kofler heated stage and are 
uncorrected. NMR spectra were recorded on a Bruker AC300MHz in CDCl3 as solvent. COSY 
experiments were done for all compounds. HRMS (EI) determinations were made using a VG 
Autospec Trio 1000 (Fisons). Infrared spectra were recorded in KBr discs on a Bio-Rad FTS-7. 
 
[1,2,3]Triazolo[1,5-a]pyridine 1a, 3-methyl-[1,2,3]triazolo[1,5-a]pyridine 1b, 3-(2-thienyl)-
[1,2,3]triazolo[1,5-a]pyridine 1c and 3-(2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 1d.  
Prepared as described elsewhere.8,9,5 
 
General procedure for lithiation of [1,2,3]triazolo[1,5-a]pyridines 1 
To a solution of the corresponding [1,2,3]triazolo[1,5-a]pyridine 1 (1g) in anhydrous toluene 
(50mL) at -40ºC, a solution of n-butyllithium in hexane (5mL, 2.5M) was added with stirring. A 
deep red colour developed. The mixture was kept at -40ºC (4h). Treatment with a dry toluene 
solution (40mL) of an equimolar amount of the 2-cyanopyridine produced a change to yellow 
colour. The mixture was left at room temperature overnight, treated with 10% solution of HCl 
(5mL), stirried for 1h and neutralised with aqueous NaOH. The organic layer was separated and 
the aqueous layer extracted with dichloromethane. After drying over anhydrous Na2SO4 and 
evaporation of the organic solvents, a residue was obtained which was purified. The conditions 
of the purification are given for each compound. 
2-Pyridyl-[1,2,3]triazolo[1,5-a]pyridin-7-ylmethanone (5a) and 7,9-di(2-pyridyl)-[1,2,3] 
triazolo[5',1':6,1]pyrido[3,2-d]pyrimidine (11a). Purification by alumina (IV) 
chromatography, elution with ethyl acetate/hexane with increasing amount of ethyl acetate gave 
first starting material 1a (15%), then a yellow solid identified as 5a (15% yield). Mp 158-160 ºC 
(AcOEt). HRMS found M+ 224.0691; C12H8N4O requires 224.0698. νmax (KBr) (cm-1) 
1688(CO), 1596, 1322, 1287, 814, 741. λmax (nm) (log ε) 235 (4.31), 275.5 (3.99), 356.5 (3.55). 
1H NMR δ 8.44 (ddd, J1= 4.71, J2= 1.68, J3= 0.93Hz, 1H), 8.15 (ddd, J1= 7.71, J2= 1.10, J3= 
0.93Hz, 1H), 8.07 (s, 1H), 7.88 (ddd, J1= J2= 7.71, J3= 1.68Hz, 1H), 7.84 (dd, J1= 8.85, J2= 
1.50Hz, 1H), 7.43 (ddd, J1= 7.71, J2= 4.71, J3= 1.10Hz, 1H), 7.37 (dd, J1= 6.78, J2= 1.50Hz, 1H), 
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7.29 (dd, J1= 8.85, J2= 6.78Hz, 1H). 13C NMR δ 188.60 (CO), 153.38 (C), 149.58 (CH), 137.80 
(CH), 134.96 (C), 134.41 (C), 128.14 (CH), 126.23 (CH), 125.01 (CH), 124.27 (CH), 121.08 
(CH), 118.84 (CH). MS m/z (%), 224 (45), 196 (80), 168 (16), 132 (36), 106 (55), 78 (100), 63 
(11). Further elution gave the alcohol 15 as a yellow solid. (5% yield). Mp 211-212 ºC (DMSO). 
HRMS found M+ 214.0744; C12H10N2O2 requires 214.0742. νmax (KBr) (cm-1) 3523, 3434(OH), 
1669(CO), 1591, 1322, 989, 952, 826, 748. λmax (nm) (log ε) 204.5 (4.06), 239.0 (4.13), 280.5 
(4.22), 291.5 (4.21). 1H NMR δ 8.74 (d, J= 4.5, 1H), 8.19-8.06 (m, 4H), 7.88 (d, J= 8.28Hz, 1H), 
7.72-7.67 (m, 1H), 7.06 (br s, 1H), 6.64 (s, 2H). 13C NMR δ 193.64 (CO), 149.45 (CH), 142.17 
(C), 141.05 (CH), 138.12 (CH), 137.49 (CH), 127.29 (CH), 125.08 (CH), 123.63 (CH), 122.37 
(CH), 60.52 (CH2). MS m/z (%), 214 (100), 213 (8), 185 (33), 169 (56), 108 (34), 78 (93). Then 
compound 16 was eluted as an oil (2% yield). HRMS found M+ 299.1177; C18H13N5 requires 
299.1171. νmax (KBr) (cm-1) 3057, 1600, 1555, 1463, 1371, 1336, 1269, 999, 796, 750. 1H NMR 
δ 9.25 (d, J= 8.5, 1H), 8.83-8.82 (m, 2H), 8.75 (ddd, J1= 4.89, J2= 1.70, J3= 0.75Hz, 1H), 8.47 
(dd, J1= 7.92, J2= 0.93Hz, 1H), 7.93-7.81 (m, 2H), 7.42 (d, J= 8.5Hz, 1H), 7.44-7.35 (m, 2H), 
2.80 (s, 3H). 13C NMR δ 168.65 (C), 166.53 (C), 162.61 (C), 160.26 (C), 156.31 (C), 155.21 (C), 
150.39 (CH), 149.12 (CH), 137.98 (CH), 137.94 (CH), 137.32 (CH), 126.35 (CH), 125.42 (CH), 
125.35 (CH), 125.11 (CH), 124.84 (CH), 115.83 (C), 26.41 (CH3). The last compound eluted 
was 11a. Yellow solid. (7% yield). Mp 256-258 ºC (EtOH). HRMS found M+ 325.1078; 
C18H11N7 requires 325.1076. νmax (KBr) (cm-1) 1608, 1562, 1532, 1511, 1395, 1373, 776, 719. 
λmax (nm) (log ε) 237.0 (4.35), 285.5 (4.40), 359.0 (4.17). 1H NMR δ 8.87 (ddd, J1= 4.71, J2= 
1.70Hz, J3= 0.96, 1H), 8.84 (d, J= 7.92Hz, 1H), 8.77 (d, J= 9.60Hz, 1H), 8.77 (dd, J1= 1.7, J2= 
0.96Hz, 1H), 8.52 (d, J= 7.92, 1H), 8.16 (s, 1H), 7.97-7.87 (m, 2H), 7.64 (d, J= 9.61Hz, 1H), 
7.48-7.40 (m, 2H). 13C NMR δ 164.10 (C), 161.70 (C), 155.55 (C), 153.65 (C), 150.40 (CH), 
149.21 (C), 148.91 (CH), 137.66 (CH), 137.22 (CH), 134.13 (C), 128.44 (CH), 126.08 (CH), 
125.64 (CH), 125.21 (CH), 125.09 (CH), 124.46 (CH), 117.14 (CH), 113.35 (C). MS m/z (%), 
325 (57), 297 (100), 271 (16), 193 (22), 78 (22). 
2-Pyridyl-3-methyl-[1,2,3]triazolo[1,5-a]pyridin-7-ylmethanone (5b) and 3-methyl-7,9-di(2-
pyridyl)[1,2,3]triazolo [5',1':6,1]pyrido[3,2-d]pyrimidine (11b). Purification by chromatotron, 
elution with ethyl acetate/hexane with increasing amount of ethyl acetate gave first starting 
material 1b (15%), then an oil identified as 19 (5% yield). HRMS found M+ 239.1171; C13H13N5 
requires 239.1171. νmax (KBr) (cm-1) 3367 (broad), 1638, 1591, 1470, 1436. 1H NMR δ 8.46 (d, 
J= 4.71, 1H), 7.60-7.59 (m, 2H), 7.46 (dd, J1= 8.85, J2= 1.14Hz, 1H), 7.13-7.09 (m, 2H), 6.68 (d, 
J= 6.96, 1H), 5.95 (s, 1H), 4.75 (br s, 2H), 2.53 (s, 3H). 13C NMR δ 159.25 (C), 143.95 (CH), 
141.21 (C), 136.78 (CH), 134.66 (C), 132.05 (C), 124.01 (CH), 123.03 (CH), 122.73 (CH), 
115.93 (CH), 112.42 (CH), 56.10 (CH), 10.44 (CH3). MS m/z (%), 239 (3), 211 (59), 107 (100). 
This was followed by a yellow solid identified as 5b (34% yield). Mp 165-167 ºC (AcOEt). 
HRMS found M+ 238.0853; C13H10N4O requires 238.0854. νmax (KBr) (cm-1) 3048, 1692(CO), 
1580, 1544, 1437, 1315, 1285, 1020, 775, 745. 1H NMR δ 8.45 (ddd, J1= 4.71, J2= 1.70, J3= 
0.93Hz, 1H), 8.15 (ddd, J1= 7.71, J2= 1.32, J3= 0.93Hz, 1H), 7.88 (ddd, J1= J2= 7.71, J3= 1.70Hz, 
1H), 7.73 (dd, J1= 8.64, J2= 1.11Hz, 1H), 7.43 (ddd, J1= 7.71, J2= 4.71, J3= 1.32Hz, 1H), 7.34 
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(dd, J1= 6.78, J2= 1.11Hz, 1H), 7.23 (dd, J1= 8.64, J2= 6.78Hz, 1H), 2.57 (s, 3H). 13C NMR δ 
188.71 (CO), 153.53 (C), 149.54 (CH), 137.73 (CH), 135.09 (C), 134.79 (C), 132.39 (C), 127.99 
(CH), 124.26 (CH), 123.38 (CH), 120.80 (CH), 118.89 (CH), 10.79 (CH3). MS m/z (%), 238 
(42), 210, (100), 209 (57), 182 (22), 181 (98), 156 (15), 155 (9), 106 (8), 104 (23), 78 (57). 
Further elution gave 20 (5% yield). Mp 238-240 ºC (AcOEt/hexane), lit.4 238-240 ºC 
(AcOEt/hexane). The last compound eluted was 11b. Yellow solid. (24% yield). Mp 255-257 ºC 
(AcOEt). HRMS found M+ 339.1233; C19H13N7 requires 339.1232. νmax (KBr) (cm-1) 1618, 
1561, 1547, 1377, 776. λmax (nm) (log ε) 232.0 (5.35), 285.5 (5.33), 374.5 (4.12). 1H NMR δ 
8.87 (ddd, J1= 4.71, J2= 1.68, J3= 0.93Hz, 1H), 8.81 (ddd, J1= 7.89, J2= 1.71, J3= 0.93 Hz, 1H), 
8.77 (ddd, J1= 4.71, J2= 1.71, J3= 0.75 Hz, 1H), 8.65 (d, J= 9.6Hz, 1H), 8.49 (ddd, J1= 7.89, J2= 
1.68, J3= 0.75Hz, 1H), 7.97-7.86 (m, 2H), 7.51 (d, J= 9.6Hz, 1H), 7.48-7.40 (m, 2H), 2.64 (s, 
3H). 13C NMR δ 163.75 (C), 161.40 (C), 155.65 (C), 153.68 (C), 150.33 (CH), 149.38 (C), 
148.89 (CH), 137.59 (CH), 137.59 (C), 137.19 (CH), 131.50 (C), 125.87 (CH), 125.59 (CH), 
125.12 (CH), 125.00 (CH), 122.80 (CH), 117.00 (CH), 113.51 (C), 10.36 (CH3). MS m/z (%), 
339 (13), 311 (100), 206 (10). 
2-Pyridyl-3-(2-thienyl)[1,2,3]triazolo[1,5-a]pyridin-7-ylmethanone 5c and 7,9-di(2-pyridyl)-
3-(2-thienyl)-[1,2,3]triazolo [5',1':6,1]pyrido[3,2-d]pyrimidine (11c). Purification by 
chromatotron, elution with ethyl acetate/hexane with increasing amount of ethyl acetate gave 
first starting material 1c (15%), then a yellow solid identified as 5c (15% yield). Mp 172-174 ºC 
(AcOEt). HRMS found M+ 306.0575; C16H10N4OS requires 306.0575. νmax (KBr) (cm-1) 
1679(CO), 1578, 1438, 1311, 1216, 825, 725. λmax (nm) (log ε) 249.5 (4.29), 281.0 (4.30), 401.0 
(3.71). 1H NMR δ 8.45 (ddd, J1= 4.71, J2= 1.68, J3= 0.93Hz, 1H), 8.16 (ddd, J1= 7.89, J2= 1.11, 
J3= 0.96Hz, 1H), 8.09 (dd, J= 5.1, J2= 0.96, 1H), 7.89 (ddd, J1= J2= 7.74, J3= 1.61Hz, 1H), 7.52 
(dd, J1= 3.75, J2= 1.11Hz, 1H), 7.44 (ddd, J1= 7.74, J2= 4.79, J3= 1.11Hz, 1H), 7.38 (d, J= 5.1, 
1H), 7.38 (d, J= 4.89, 1H), 7.32 (dd, J1= 5.10, J2= 1.11Hz, 1H), 7.11 (dd, J1= 4.53, J2= 3.57Hz, 
1H). 13C NMR δ 188.24 (CO), 152.94 (C), 149.22 (CH), 137.32 (CH), 135.04 (C), 133.60 (C), 
132.94 (C), 129.93 (C), 127.78 (CH), 127.72 (CH), 125.28 (CH), 125.13 (CH), 124.20 (CH), 
123.67 (CH), 120.86 (CH), 118.33 (CH). MS m/z (%), 306 (9), 278 (100), 249 (15), 200 (8), 172 
(26), 78 (24). The last compound eluted was 11c. Yellow solid. (15% yield). Mp 248-250 ºC 
(cyclohexane). HRMS found M+ 407.0968; C22H13N7S requires 407.0953. νmax (KBr) (cm-1) 
1609, 1573, 1558, 1507, 1462, 1427, 1378, 777, 723. λmax (nm) (log ε) 247.0 (4.36), 288.0 
(4.41), 408.0 (4.05). 1H NMR δ 8.88 (ddd, J1= 4.71, J2= 1.70Hz, J3= 0.96, 1H), 8.84 (d, J= 
9.60Hz, 1H), 8.83 (d, J= 7.89Hz, 1H), 8.78 (ddd, J1= 4.89, J2= 1.68, J3= 0.93Hz, 1H), 8.53 (d, J= 
7.92, 1H), 7.97-7-91 (m, 2H), 7.86 (d, J= 9.60Hz, 1H), 7.64 (dd, J1= 3.57, J2= 1.11Hz, 1H), 7.48-
7.42 (m, 2H), 7.39 (dd, J1= 5.07, J2= 1.11Hz, 1H), 7.15 (dd, J1= 5.07, J2= 3.57Hz, 1H). 13C NMR 
δ 163.78 (C), 161.74 (C), 155.47 (C), 153.59 (C), 150.35 (CH), 149.38 (C), 148.90 (CH), 137.60 
(CH), 137.22 (CH), 136.33 (C), 132.12 (C), 129.42 (C), 127.96 (CH), 126.00 (2CH), 125.67 
(CH), 125.26 (CH), 125.21 (CH), 125.10 (CH), 124.73 (CH), 117.36 (CH), 113.65 (C). MS m/z 
(%), 407 (8), 379 (100), 378 (25), 334 (6), 284 (6), 78 (6). 
2-Pyridyl-3-(2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridin-7-ylmethanone 5d. 
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Compound 5d was obtained with 38% yield. Two crystalline phases can be obtained from 
AcOEt/hexane. At 194-195 ºC there is a phase transition forming needles that melt at 220-221ºC. 
lit.5 m.p.194-195 ºC (AcOEt/hexane). 
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